Macrophage involvement in Epstein-Barr virus-related tumors

Experimental and Therapeutic Medicine

Volumn 1, Issue 2, 2010, Pages 285-291

  Shimakage, Misuzu ^a   Sakamoto, Haruhiko ^b  

^a National Hospital Organization Wakayama Hospital   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Epstein Barr virus; In situ hybridization; Inflammation; Macrophage

Indexed keywords

CHLORDANE; IMMEDIATE EARLY PROTEIN BZLF1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CARCINOMA; LARGE CELL LYMPHOMA; MACROPHAGE; MOUTH CANCER; NASOPHARYNX CARCINOMA; TESTIS CARCINOMA; THYROID CARCINOMA; TISSUE SECTION; TUMOR; UTERUS CARCINOMA; VIRUS ONCOGENE;

EID: 77956206322     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000044     Document Type: Article

References (35)

1. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
2. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
3. IARC World Cancer Report. Chronic Inflammations. IARC Press, Lyon, pp56-61. 2003.
4. Shimakage M, Horii K, Tempaku A, Kakudo K, Shirasaka T and Sasagawa T: Association of Epstein-Barr virus with oral cancers. Hum Pathol 33: 608-614, 2002.
5. Shimakage M, Sasagawa T, Yoshino K, Yutsudo M, Kimura M, Yamamoto N and Yanoma S: Expression of Epstein-Barr virus in mesopharyngeal and hypopharyngeal carcinomas. Hum Pathol 30: 1071-1076, 1999.
6. Shimakage M, Kawahara K, Sasagawa T, Inoue H, Yutsudo M, Yoshida A and Yanoma S: Expression of Epstein-Barr virus in thyroid carcinoma correlates with tumor progression. Hum Pathol 34: 1170-1177, 2003.
7. Shimakage M, Kawahara K, Harada S, Sasagawa T, Shinka T and Oka T: Expression of Epstein-Barr virus in renal cell carcinoma. Oncol Rep 18: 41-46, 2007.
8. Shimakage M, Oka T, Shinka T, Kurata A, Sasagawa T and Yutsudo M: Involvement of Epstein-Barr virus expression in testicular tumors. J Urol 156: 253-257, 1996.
9. Sasagawa T, Shimakage M, Nakamura M, Sakaike J, Ishikawa H H and Inoue M: Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasm and invasive cervical cancer: a comparative study with human papillomavirus (HPHPV) infection. Hum Pathol 31: 318-326, 2000.
10. Shimakage M and Sasagawa T: Detection of Epstein-Barr virus-determined nuclear antigen-2 mRNARNARNA by in situ hybridization. J Virol Methods 93: 23-32, 2001.
11. Shimakage M, Harada S, Kawahara K, Oka T, Yanoma S, Horii K K and Sasagawa T: Detection of Epstein-Barr virus nuclear antigen leader protein expression in various human cancers. In: New Developments in Epstein-Barr Virus Research. Umar CSCS (ed). Nova Science Publishers, New York, pp261-276, 2006.
12. Shimakage M, Dezawa T, Tamura S, Tabata T, Aoyagi N, Koike M, Inoue H, Yutsudo M, Hakura A and Ikegami N: A Ki-1-positive cell line expressing Epstein-Barr virus antigen established from a child with Ki-positive lymphoma. Intervirology 36: 215-224, 1993.
13. Shimakage M, Nakamine H, Tamura S, Takenaka T, Yutsudo M M and Hakura A: Detection of Epstein-Barr virus transcripts in anaplastic large-cell lymphomas by mRNA in situ hybridization. Hum Pathol 28: 1415-1419, 1997.
14. Shimakage M, Sasagawa T, Kawahara K, Yutsudo M, Kusuoka H and Kozuka T: Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides. Int J Cancer 92: 226-231, 2001.
15. Nakajima H, Shimakage M, Takeda Y, Furutama D, Sugino M, Kimura F, Shibayama Y and Hanafusa T: Epstein-Barr virus-associated primary leptomeningeal lymphoma. Eur J Neurol 13: e4-e6, 2006.
16. Shimakage M, Sakamoto H, Harada S, Sasagawa T and Kodama K K: Expression of the Epstein-Barr virus in lymphoproliferative diseases of the lung. Oncol Rep 17: 1347-1352, 2007.
17. Hoshikawa Y, Satoh Y, Murakami M, Maeta M, Kaibara N, Ito H, Kurata T and Sairenji T: Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carinoma. J Med Virol 99: 351-359, 2002.
18. Takasaka N, Tajima M, Okinaga K, Satoh Y, Hoshikawa Y, Katsumoto T, Kurata T and Sairenji T: Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GTGT38 and GTGT39) derived from gastric tissues. Virology 247: 152-159, 1998.
19. Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res 66: 605-612, 2006.
20. Revoltella RPRP, Vigneti E, Fruscalzo A, Park M, Ragona G, Rocchi G and Calef E: Epstein-Barr virus DNADNADNA sequences in precursor monocyte-macrophage cell line established from the bone marrow of children with maturation defects of haematopoiesis. J Gen Virol 70: 1203-1215, 1989.
21. Savard M, Belanger C, Tardif M, Gourde P, Flamand L and Gosselin J: Infection of primary human monocytes by Epstein-Barr virus. J Virol 74: 2612-2619, 2000.
22. Shimakage M, Kimura M, Yanoma S, Ibe M, Yokota S, Tsujino G G, Kozuka T, Dezawa T, Tamura S, Ohshima A, Yutsudo M M and Hakura A: Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage. Arch Virol 144: 157-166, 1999.
23. Shimakage M, Sasagawa T, Kimura M, Shimakage T, Seto S, Kodama K and Sakamoto H: Expression of Epstein-Barr virus in Langerhans' cell histiocytosis. Hum Pathol 35: 862-868, 2004.
24. Shimakage M: Langerhans cell histiocytosis and its relationship with Epstein-Barr virus - reply. Hum Pathol 37: 1509-1511, 2006.
25. Tierney RJ, Steven N, Young LSLS and Rickinson AB: Epstein-Barr virus latency in blood mononuclear cells, analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68: 7374-7385, 1994.
26. Hammes LSLS, Tekmal RRRR, Naud P, Edelweiss MIMI, Kirma N, Valente PTPT, Syrjanen KJ and Cunha-Filho JS: Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression - clinicopathological correlation. Gynecol Oncol 105: 157-165, 2007.
27. Soeda S, Nakamura N, Ozeki T, Nishiyama H, Hojo H, Yamada H H, Abe M and Sato A: Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma. Gynecol Oncol 109: 122-128, 2008.
28. Hamada I, Kato M, Yamasaki T, Iwabuchi K, Watanabe T, Yamada T, Isoyama S, Ito H and Okada K: Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma. Anticancer Res 22: 4281-4284, 2002.
29. Kawanishi S, Hiraku Y, Pinlaor S and Ma N: Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 387: 365-372, 2006.
30. Ma N, Kawanishi M, Hiraku Y, Murata M, Huang GW, Huang Y, Luo DZ, Mo WG, Fukui Y and Kawanishi S: Reactive nitrogen species-dependent DNADNADNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STATSTATSTATSTAT3 activation and EGFR expression. Int J Cancer 122: 2517-2525, 2008.
31. Chayarit P, Ma N, Hiraku Y, Pinlaor S, Yangvanit P, Jintakanon D D, Murata M, Oikawa S and Kawanishi S: Nitrative and oxidative DNADNADNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci 96: 553-559, 2006.
32. Grivel J-C, Ito Y, Faga G, Santoro F, Shaheen F, Malnati MS, Fitzgerald W, Lusso P and Margolis L: Suppression of CCRCCRCCR5- but not CXCRCXCRCXCRCXCR4-tropic HIHIV-1 in lymphoid tissue by human herpesvirus 6. Nat Med 7: 1232-1235, 2001.
33. Lisco A, Grivel JC, Biancotto A, Vanopouille C, Origgi F, Malnati MS, Schols D, Lusso P and Margolis LB: Viral interaction in human lymphoid tissue: human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CDCD4 modulation. J Virol 81: 708-717, 2007.
34. Barton ES, White DW, Cathelyn JS, Brett-McClellan KAKA, Engle M M, Diamond D, Miller VL and Virgin HW IV: Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447: 326-330, 2007.
35. Sasagawa T: Human papillomavirus infection and cervical cancer. Biomed Rev 14: 75-93, 2003.